Moore T - Search Results

1

Identification of a hepatitis C virus-reactive T cell receptor that does not require CD8 for target cell recognition.

Callender GG, Rosen HR, Roszkowski JJ, Lyons GE, Li M, Moore T, Brasic N, McKee MD, Nishimura MI. Callender GG, et al. Among authors: moore t. Hepatology. 2006 May;43(5):973-81. doi: 10.1002/hep.21157. Hepatology. 2006. PMID: 16628627

2

A new murine tumor model for studying HLA-A2-restricted anti-tumor immunity.

Kaplan BL, Moore TV, Schreiber K, Callender GG, Schreiber H, Nishimura MI. Kaplan BL, et al. Cancer Lett. 2005 Jun 16;224(1):153-66. doi: 10.1016/j.canlet.2004.11.035. Epub 2004 Dec 25. Cancer Lett. 2005. PMID: 15911111

3

Antigen recognition and T-cell biology.

Nishimura MI, Roszkowski JJ, Moore TV, Brasic N, McKee MD, Clay TM. Nishimura MI, et al. Cancer Treat Res. 2005;123:37-59. doi: 10.1007/0-387-27545-2_2. Cancer Treat Res. 2005. PMID: 16211865 Review.

4

Influence of human CD8 on antigen recognition by T-cell receptor-transduced cells.

Lyons GE, Moore T, Brasic N, Li M, Roszkowski JJ, Nishimura MI. Lyons GE, et al. Among authors: moore t. Cancer Res. 2006 Dec 1;66(23):11455-61. doi: 10.1158/0008-5472.CAN-06-2379. Cancer Res. 2006. PMID: 17145893

5

ICOS costimulation expands Th2 immunity by augmenting migration of lymphocytes to draining lymph nodes.

Tesciuba AG, Shilling RA, Agarwal MD, Bandukwala HS, Clay BS, Moore TV, Weinstock JV, Welcher AA, Sperling AI. Tesciuba AG, et al. J Immunol. 2008 Jul 15;181(2):1019-24. doi: 10.4049/jimmunol.181.2.1019. J Immunol. 2008. PMID: 18606653 Free PMC article.

6

Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition.

Moore TV, Lyons GE, Brasic N, Roszkowski JJ, Voelkl S, Mackensen A, Kast WM, Le Poole IC, Nishimura MI. Moore TV, et al. Cancer Immunol Immunother. 2009 May;58(5):719-28. doi: 10.1007/s00262-008-0594-2. Epub 2008 Oct 3. Cancer Immunol Immunother. 2009. PMID: 18836717 Free PMC article.

7

Characterization of MHC class-I restricted TCRalphabeta+ CD4- CD8- double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination.

Voelkl S, Moore TV, Rehli M, Nishimura MI, Mackensen A, Fischer K. Voelkl S, et al. Cancer Immunol Immunother. 2009 May;58(5):709-18. doi: 10.1007/s00262-008-0593-3. Epub 2008 Oct 3. Cancer Immunol Immunother. 2009. PMID: 18836718 Free PMC article.

8

Engagement of NK receptor NKG2D, but not 2B4, results in self-reactive CD8+ T cells and autoimmune vitiligo.

Zloza A, Lyons GE, Chlewicki LK, Kohlhapp FJ, O'Sullivan JA, Lacek AT, Moore TV, Jagoda MC, Kumar V, Guevara-Patiño JA. Zloza A, et al. Among authors: moore tv. Autoimmunity. 2011 Dec;44(8):599-606. doi: 10.3109/08916934.2011.593599. Epub 2011 Sep 13. Autoimmunity. 2011. PMID: 21913803

9

NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses.

Zloza A, Kohlhapp FJ, Lyons GE, Schenkel JM, Moore TV, Lacek AT, O'Sullivan JA, Varanasi V, Williams JW, Jagoda MC, Bellavance EC, Marzo AL, Thomas PG, Zafirova B, Polić B, Al-Harthi L, Sperling AI, Guevara-Patiño JA. Zloza A, et al. Among authors: moore tv. Nat Med. 2012 Feb 26;18(3):422-8. doi: 10.1038/nm.2683. Nat Med. 2012. PMID: 22366950 Free PMC article.

10

CD8(+) T cells sabotage their own memory potential through IFN-γ-dependent modification of the IL-12/IL-15 receptor α axis on dendritic cells.

Kohlhapp FJ, Zloza A, O'Sullivan JA, Moore TV, Lacek AT, Jagoda MC, McCracken J, Cole DJ, Guevara-Patiño JA. Kohlhapp FJ, et al. Among authors: moore tv. J Immunol. 2012 Apr 15;188(8):3639-47. doi: 10.4049/jimmunol.1101580. Epub 2012 Mar 19. J Immunol. 2012. PMID: 22430740 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,146 results

Search Page